Vir Biotechnology
$9.55
24H
Market Cap
Volume
Supply
Price Chart
About Vir Biotechnology - VIR
Vir Biotechnology, Inc. is a biotechnology company focused on the research and development of treatments for serious infectious diseases, including those caused by viruses and bacteria. They aim to address global health needs through innovative therapeutic approaches.
What are Vir Biotechnology's core values and mission statement?
Vir Biotechnology, Inc. is dedicated to addressing serious infectious diseases by combining immunologic insights with cutting-edge technologies. The company's mission is to transform the care of people with serious infectious diseases by curing, preventing, or effectively treating these diseases wherever they emerge.
Who founded Vir Biotechnology and when?
Vir Biotechnology, Inc. was founded by a group of biotechnology veterans including Robert Nelsen of ARCH Venture Partners, and it was established in 2016.
Who leads Vir Biotechnology?
As of the last update, George Scangos is the CEO of Vir Biotechnology, Inc.
Where is Vir Biotechnology located, and what is its base country?
Vir Biotechnology, Inc. is headquartered in San Francisco, California, and its base country is the United States of America.
On which exchanges is Vir Biotechnology traded?
Vir Biotechnology, Inc. is publicly traded on the Nasdaq Stock Market under the ticker symbol VIR.
Historical data
Vir Biotechnology (VIR) Price Live Data
The live price of Vir Biotechnology (VIR) is $9.55, with a trading volume of 588,471 in the last 24 hours. Wrapstocks updates the VIR price in real-time. Vir Biotechnology is down -2.25% in the last 24 hours. The company has a live market cap of $1,315,225,984.00 and a supply of 137,719,998 VIR stocks.
Vir Biotechnology (VIR) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 5 hours and 23 minutes.
